Edition:
United States

People: Aldeyra Therapeutics Inc (ALDX.A)

ALDX.A on American Stock Exchange

5.60USD
12 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.60
Open
$5.60
Day's High
$5.60
Day's Low
$5.60
Volume
100
Avg. Vol
529
52-wk High
$16.55
52-wk Low
$5.01

Brady, Todd 

Dr. Todd C. Brady is President and Chief Executive Officer Director of Company. From April 2013 to December 2013, Dr. Brady has served as President and Chief Executive Officer since January of 2012 and as a member of our Board of Directors since 2005. Prior to Aldeyra, Dr. Brady served as Entrepreneur in Residence at Domain Associates, LLC, a leading healthcare venture capital firm, where he was a Principal from 2004 to 2013. Dr. Brady currently serves on the Board of Directors of Evoke Pharma, Inc. and Spring Bank Pharmaceuticals, Inc., both of which are publicly traded healthcare companies. Dr. Brady served on the Board of Directors of Oncobiologics, Inc. from 2014 to 2017. Dr. Brady holds a Ph.D. in pathology from Duke University Graduate School, a M.D. from Duke University Medical School, and an A.B. from Dartmouth College in Philosophy and Psychology. Dr. Brady’s extensive knowledge of our business, as well as his years of experience in the biotechnology industry, including executive leadership in several biotechnology companies, contributed to our conclusion that he should serve as a director of our company.

Basic Compensation

Total Annual Compensation, USD 473,000
Restricted Stock Awards, USD 697,711
Long-Term Incentive Plans, USD 239,800
All Other, USD 955,632
Fiscal Year Total, USD 2,366,140

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --